Teacher Retirement System of Texas Trims Holdings in Inspire Medical Systems, Inc. (NYSE:INSP)

Teacher Retirement System of Texas reduced its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 38.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,371 shares of the company's stock after selling 5,308 shares during the quarter. Teacher Retirement System of Texas' holdings in Inspire Medical Systems were worth $1,333,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of INSP. Huntington National Bank grew its holdings in Inspire Medical Systems by 228.3% during the 4th quarter. Huntington National Bank now owns 174 shares of the company's stock worth $32,000 after acquiring an additional 121 shares during the last quarter. Parallel Advisors LLC lifted its position in shares of Inspire Medical Systems by 356.5% during the first quarter. Parallel Advisors LLC now owns 210 shares of the company's stock worth $33,000 after purchasing an additional 164 shares in the last quarter. True Wealth Design LLC lifted its position in shares of Inspire Medical Systems by 39.0% during the fourth quarter. True Wealth Design LLC now owns 196 shares of the company's stock worth $36,000 after purchasing an additional 55 shares in the last quarter. Harbour Investments Inc. increased its holdings in shares of Inspire Medical Systems by 101.0% in the fourth quarter. Harbour Investments Inc. now owns 197 shares of the company's stock valued at $37,000 after purchasing an additional 99 shares in the last quarter. Finally, AlphaQuest LLC raised its position in Inspire Medical Systems by 7,275.0% in the 4th quarter. AlphaQuest LLC now owns 295 shares of the company's stock worth $55,000 after purchasing an additional 291 shares during the last quarter. 94.91% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Inspire Medical Systems

In other Inspire Medical Systems news, Director Shawn Mccormick sold 360 shares of the company's stock in a transaction on Friday, May 2nd. The shares were sold at an average price of $160.00, for a total transaction of $57,600.00. Following the transaction, the director owned 24,046 shares in the company, valued at approximately $3,847,360. This represents a 1.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 2.30% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on INSP shares. Wall Street Zen upgraded Inspire Medical Systems from a "hold" rating to a "buy" rating in a research report on Saturday. Wells Fargo & Company decreased their price target on Inspire Medical Systems from $195.00 to $174.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. JPMorgan Chase & Co. lowered their price target on shares of Inspire Medical Systems from $235.00 to $195.00 and set an "overweight" rating for the company in a research report on Tuesday, May 6th. KeyCorp lowered their price target on shares of Inspire Medical Systems from $234.00 to $216.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Finally, Stifel Nicolaus reduced their price objective on shares of Inspire Medical Systems from $190.00 to $175.00 and set a "hold" rating on the stock in a research note on Monday, April 21st. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $211.91.

Inspire Medical Systems Stock Performance

Shares of NYSE:INSP traded down $0.10 during midday trading on Monday, hitting $130.17. 767,421 shares of the stock were exchanged, compared to its average volume of 544,919. The business's 50-day moving average price is $139.08 and its 200 day moving average price is $161.29. Inspire Medical Systems, Inc. has a 12 month low of $123.00 and a 12 month high of $225.00. The stock has a market capitalization of $3.84 billion, a price-to-earnings ratio of 59.98, a P/E/G ratio of 1.99 and a beta of 1.25.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $0.10 EPS for the quarter, beating analysts' consensus estimates of ($0.23) by $0.33. The firm had revenue of $201.32 million for the quarter, compared to analyst estimates of $194.89 million. Inspire Medical Systems had a return on equity of 10.00% and a net margin of 7.92%. The business's revenue was up 22.7% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.34) EPS. As a group, sell-side analysts expect that Inspire Medical Systems, Inc. will post 2.16 EPS for the current year.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.